Foot Dermatoses Completed Phase 4 Trials for Amorolfine (DB09056)

IndicationStatusPhase
DBCOND0074620 (Foot Dermatoses)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02321098Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic VarnishTreatment
NCT02705664Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1%Treatment
NCT02679911Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail LacquerTreatment